Exagen Inc. (XGN) Financials
XGN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 50.8 million | 30.8 million |
| 2023-12-31 | 56.9 million | 34.3 million |
| 2023-09-30 | 60.9 million | 33.4 million |
| 2023-06-30 | 64.2 million | 32.3 million |
XGN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -9.1 million | 553000 |
| 2023-12-31 | 8.2 million | 763000 |
| 2023-09-30 | -2.9 million | 890000 |
| 2023-06-30 | -10.5 million | 978000 |
XGN Net Income
No data available :(
XGN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 27.3 million | - | - |
| 2023-12-31 | 36.5 million | - | 4.2 million |
| 2023-09-30 | 28.4 million | - | 4.8 million |
| 2023-06-30 | 31.5 million | - | 5.0 million |
XGN Shares Outstanding
XGN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 86000 | 1.1 million | - | - |
| 2023-12-31 | 106000 | 1.1 million | 34.0 million | 300000 |
| 2023-09-30 | 2000 | 1.4 million | 10.9 million | 500000 |
| 2023-06-30 | 324000 | 1.3 million | 11.6 million | 400000 |
XGN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 14.4 million | 5.8 million |
| 2023-12-31 | 13.8 million | 5.6 million |
| 2023-09-30 | 13.4 million | 5.7 million |
| 2023-06-30 | 14.1 million | 5.8 million |
XGN
Price: $1.88
52 week price:
Earnings Per Share: -1.34 USD
P/E Ratio: -1.11
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 10300
Market Capitalization: 33.2 million